Cantor Fitzgerald reiterated its confidence in ORIC Pharmaceuticals (NASDAQ:ORIC), maintaining an Overweight stock rating.

Howard Lutnick, the chairman of Cantor Fitzgerald and nominee for U.S. Commerce Secretary, faced questioning from Senate Democrats regarding the financial firm's investment in Tether, the entity ...

Equities research analysts at Cantor Fitzgerald lifted their FY2025 earnings per share (EPS) estimates for KLA in a note issued to investors on Friday, January 31st. Cantor Fitzgerald analyst C. Muse ...

Cantor Fitzgerald analyst Kristen Kluska maintained a Buy rating on PTC Therapeutics (PTCT – Research Report) today and set a price target of ...

Howard Lutnick, chairman and CEO of investment firms Cantor Fitzgerald and BGC Group, told the U.S. Senate Committee on ...

TMC the metals company Inc (TMC) stock saw a modest uptick, ending the day at $1.78 which represents a slight increase of $0.15 or 9.20% from the prior close of $1.63. The stock opened at $1.58 and ...

Cantor Fitzgerald analyst Troy Jensen maintained a Buy rating on Stratasys (SSYS – Research Report) today and set a price target of $12.00. The ...

Howard Lutnick, President Donald Trump's nominee for Commerce Secretary and CEO of Cantor Fitzgerald, says the firm has no ...

PTC Therapeutics (PTCT) is advancing 8% after investment bank Cantor Fitzgerald’ hiked its price target on the drug maker’s ...

Asked by senators, the Commerce secretary nominee declined to commit to recusing himself despite his cryptocurrency conflicts.